Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). [PDF]
Horita N +6 more
europepmc +1 more source
The risk factors of future exacerbations and treatment responses among different inhalation therapies of patients with preserved ratio impaired spirometry. [PDF]
Cao J +12 more
europepmc +1 more source
Long-Acting Muscarinic Antagonists for the Treatment of Difficult-to-Treat and Severe Asthma: A Narrative Review Focusing on Inflammation from Bench to Bedside. [PDF]
Calzetta L +6 more
europepmc +1 more source
Association Between Improvement in Institutional COPD Quality Assessment Grade and Risk of Acute Exacerbations in Primary and Secondary Care: A Nationwide Claims-Based Study. [PDF]
Moon SW +5 more
europepmc +1 more source
Appropriate Use of Single Inhaled Triple Therapy in Uncontrolled Asthma: A Multinational Modified Delphi Consensus. [PDF]
Mungan D +11 more
europepmc +1 more source
Association between inhaled corticosteroids and risk of cardiovascular mortality in patients with COPD: a systematic review and meta-analysis. [PDF]
Yang MJ +7 more
europepmc +1 more source
FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up from Dual Therapy Stratified by Exacerbations and Prior Dual Therapy: A Subgroup Analysis of a Comparative Effectiveness Study. [PDF]
Wedzicha JA +9 more
europepmc +1 more source
Clinical Remission in Severe T2-High Asthma in Real Life After Anti-IgE, Anti-IL-5 and Anti-IL5R: A Potential Role for CRP as a Biomarker. [PDF]
Vervier J +12 more
europepmc +1 more source
Penicillin Allergy Labels, Broad-Spectrum Antibiotic Use, and Chronic Obstructive Pulmonary Disease Exacerbations: A Population-Based Cohort Study from China. [PDF]
Wu P +17 more
europepmc +1 more source
A Study on the Use of Nebulized Glycopyrronium in Hospitalized Patients With Exacerbations of Obstructive Airway Disease. [PDF]
Khanna A, Tandon A, Narasimhan R L.
europepmc +1 more source

